The Trump administration wants to increase how much Medicare pays for CAR-T cancer therapy and similar breakthrough devices and drugs that could substantially improve care for patients.
Seema Verma, administrator of the Centers for Medicare and Medicaid Services, said the agency will boost the size of extra payments it makes to help hospitals incorporate new technologies and treatments into their clinics. Medicare now pays 50 percent of the additional costs of these innovative treatments, but is proposing to increase that to 65 percent.
About the Author Reprints
